Final overall survival analysis of PROfound: olaparib vs physician's choice of enzalutamide or abiraterone in patients with metastatic castration resistant prostate cancer and homologous recombination repair (HRR) gene alterations.

Sandhu S., de Bono J., Mateo J., Fizazi K., Fred S., Shore N., ...Daha Fazla

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, cilt.16, ss.41, 2020 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 16
  • Basım Tarihi: 2020
  • Dergi Adı: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.41
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır